A phase 2 human clinical trial of an antigen for a parasitic infection caused by hookworms has been shown to be effective in ...
A phase 2 human clinical trial of an antigen for a parasitic infection caused by hookworms has been shown to be effective in ...
A CAR-T cell therapy has successfully treated not one, not two, but three different autoimmune diseases at once in a patient, providing further proof of the modality’s promise in the disease area as a ...
In recent years, CAR T-cell therapy has become a revolutionary, if risky, treatment for some late-stage cancers. Yet CAR T may also have another life as a near-miraculous intervention for certain ...
Northwestern Medicine scientists in the laboratory of Stephen Miller, Ph.D., professor emeritus of Microbiology–Immunology, have identified the cellular and molecular mechanisms required for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results